Billy Evans, accomplice of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” via blood testing, based on The New York Instances.
The Instances reportedly spoke to 2 buyers pitched on the startup, known as Haemanthus, and likewise seen a few of Haemanthus’ advertising and marketing supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to investigate blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to begin with pet well being earlier than increasing to people, and it seeks to lift greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct quite a lot of medical assessments on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two kids) was sentenced to 11 years in jail for defrauding buyers, although she mentioned in a current interview that she stays “utterly dedicated to my dream of creating reasonably priced healthcare options obtainable to everybody.”
Early Fb investor Jim Breyer advised The Instances that his crew was requested to speculate however declined “for most of the similar causes we handed twice on Theranos.”
